Susan D Croll

Summary

Affiliation: Regeneron Pharmaceuticals
Country: USA

Publications

  1. ncbi request reprint VEGF-mediated inflammation precedes angiogenesis in adult brain
    Susan D Croll
    Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA
    Exp Neurol 187:388-402. 2004
  2. ncbi request reprint Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses
    Richard Torres
    Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
    Pain 130:267-78. 2007
  3. pmc VEGF-Trap: a VEGF blocker with potent antitumor effects
    Jocelyn Holash
    Regeneron Pharmaceuticals, Incorporated, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
    Proc Natl Acad Sci U S A 99:11393-8. 2002
  4. ncbi request reprint Dexamethasone treatment and ICAM-1 deficiency impair VEGF-induced angiogenesis in adult brain
    Lora J Kasselman
    Neuropsychology Doctoral Subprogram, Graduate Center of the City University of New York, NY, USA
    J Vasc Res 44:283-91. 2007
  5. ncbi request reprint Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor
    Helen E Scharfman
    Center for Neural Recovery and Rehabilitation Research, Helen Hayes Hospital, West Haverstraw, New York, 10993 1195, USA
    Exp Neurol 174:201-14. 2002
  6. ncbi request reprint Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo
    Elhoucine Messaoudi
    Department of Physiology and Locus on Neuroscience, University of Bergen, N 5009 Bergen, Norway
    J Neurosci 22:7453-61. 2002
  7. pmc Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword
    Susan D Croll
    Department of Psychology, Queens College and the Graduate Center of the City University of New York, Flushing, USA
    Adv Exp Med Biol 548:57-68. 2004
  8. ncbi request reprint Continuous exposure to brain-derived neurotrophic factor is required for persistent activation of TrkB receptor, the ERK signaling pathway, and the induction of neuropeptide Y production in cortical cultures
    Ayalla Barnea
    Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9032, USA
    Brain Res 1020:106-17. 2004
  9. pmc Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures
    Daniel P McCloskey
    Center for Neural Recovery and Rehabilitation Research, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Neurosci 25:8889-97. 2005

Collaborators

  • George D Yancopoulos
  • John S Rudge
  • Richard Torres
  • M W Sleeman
  • Richard Ransohoff
  • Daniel P McCloskey
  • Lora J Kasselman
  • Stanley J Wiegand
  • Ayalla Barnea
  • Jocelyn Holash
  • Helen E Scharfman
  • Elhoucine Messaoudi
  • Jason W Krellman
  • Alexandra Sideris
  • Sagar Shah
  • Jennifer Kintner
  • Elizabeth Pasnikowski
  • Jodie Roberts
  • Kevin Bailey
  • Ella Ioffe
  • Tammy Huang
  • Michelle Russell
  • Clive R Bramham
  • Anne L Sollas
  • James P Fandl
  • Jeffrey H Goodman
  • Lillian Ho
  • Czeslaw Radziejewski
  • Tambudzai Kanhema
  • Donna Hylton
  • Patricia Boland
  • Sam Davis
  • Tom Daly
  • Elena Burova
  • Nick Papadopoulos
  • Shui Wang Ying
  • Ray Leidich

Detail Information

Publications9

  1. ncbi request reprint VEGF-mediated inflammation precedes angiogenesis in adult brain
    Susan D Croll
    Regeneron Pharmaceuticals, Tarrytown, NY 10591, USA
    Exp Neurol 187:388-402. 2004
    ..Furthermore, administration of low doses of VEGF induces permeability and inflammation without appreciable vascular proliferation...
  2. ncbi request reprint Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses
    Richard Torres
    Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
    Pain 130:267-78. 2007
    ..Thus, the pro-nociceptive effects of NMU in mice appear to be mediated through NMUR2, not NMUR1...
  3. pmc VEGF-Trap: a VEGF blocker with potent antitumor effects
    Jocelyn Holash
    Regeneron Pharmaceuticals, Incorporated, 777 Old Saw Mill River Road, Tarrytown, NY 10591, USA
    Proc Natl Acad Sci U S A 99:11393-8. 2002
    ..VEGF-Trap-mediated blockade may be superior to that achieved by other agents, such as monoclonal antibodies targeted against the VEGF receptor...
  4. ncbi request reprint Dexamethasone treatment and ICAM-1 deficiency impair VEGF-induced angiogenesis in adult brain
    Lora J Kasselman
    Neuropsychology Doctoral Subprogram, Graduate Center of the City University of New York, NY, USA
    J Vasc Res 44:283-91. 2007
    ..Pathological VEGF-induced angiogenesis is preceded by vascular leak and inflammation, which have been proposed to mediate subsequent angiogenesis...
  5. ncbi request reprint Spontaneous limbic seizures after intrahippocampal infusion of brain-derived neurotrophic factor
    Helen E Scharfman
    Center for Neural Recovery and Rehabilitation Research, Helen Hayes Hospital, West Haverstraw, New York, 10993 1195, USA
    Exp Neurol 174:201-14. 2002
    ..These data support the hypothesis that intrahippocampal BDNF infusion can facilitate, and potentially initiate, seizure activity in adult hippocampus...
  6. ncbi request reprint Brain-derived neurotrophic factor triggers transcription-dependent, late phase long-term potentiation in vivo
    Elhoucine Messaoudi
    Department of Physiology and Locus on Neuroscience, University of Bergen, N 5009 Bergen, Norway
    J Neurosci 22:7453-61. 2002
    ..In contrast, BDNF-LTP was completely occluded during the late phase. The results strongly support a role for BDNF in triggering transcription-dependent, late phase LTP in the intact adult brain...
  7. pmc Vascular endothelial growth factor (VEGF) in seizures: a double-edged sword
    Susan D Croll
    Department of Psychology, Queens College and the Graduate Center of the City University of New York, Flushing, USA
    Adv Exp Med Biol 548:57-68. 2004
    ..Although only further research will determine the exact nature of VEGF's role after seizures, preliminary data indicate that VEGF plays a protective role after seizures...
  8. ncbi request reprint Continuous exposure to brain-derived neurotrophic factor is required for persistent activation of TrkB receptor, the ERK signaling pathway, and the induction of neuropeptide Y production in cortical cultures
    Ayalla Barnea
    Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390 9032, USA
    Brain Res 1020:106-17. 2004
    ..We propose that, within the time frame analyzed in this study, BDNF does not lead to the downregulation of TrkB receptor or of the biological responses leading to NPY production...
  9. pmc Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures
    Daniel P McCloskey
    Center for Neural Recovery and Rehabilitation Research, Helen Hayes Hospital, West Haverstraw, New York 10993, USA
    J Neurosci 25:8889-97. 2005
    ..Based on this, we suggest that VEGF or VEGF-related targets could provide useful endpoints to direct novel therapeutic strategies for epilepsy...